Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Arlene E. Garcia-Soto"'
Autor:
Lauren E. Schwartz, J.M. Pearson, Jennifer J. Hu, Lorraine Portelance, Edward A. Jimenez, Margaret Whicker, Nathalie D. McKenzie, Joseph A. Lucci, Gordon B. Mills, Rehman Qureshi, Lilie L. Lin, Fiona Simpkins, Arlene E. Garcia-Soto, Amit Maity, Andrew V. Kossenkov
Publikováno v:
Cancer
Background Nelfinavir (NFV), an HIV‐1 protease inhibitor, has been shown to sensitize cancer cells to chemoradiation (CRT). The objectives of this phase 1 trial were to evaluate safety and identify the recommended phase 2 dose of NFV added to concu
Autor:
J.M. Pearson, Nathalie D. McKenzie, Fiona Simpkins, Arlene E. Garcia-Soto, Joseph A. Lucci, Lilie L. Lin, Lorraine Portelance
Publikováno v:
Gynecologic Oncology. 154:267-268
Autor:
Vanessa Valarezo, Michael M. Aziz, Paul B. Heller, Charbel Salamon, Brian M. Slomovitz, Nana Tchabo, Joseph Ramieri, Craig Dise, Daniel H. Tobias, Arlene E. Garcia-Soto, Kerry Graebe
Publikováno v:
Gynecologic Oncology. 136:274-277
Objective Uterine fibroids often require hysterectomy via a laparotomy or utilizing minimally invasive surgical (MIS) approach. Morcellation is a fragmentation of the uterus into smaller pieces. The objective of this study is to determine the inciden
Publikováno v:
Gynecologic Oncology Reports
Gynecologic Oncology Reports, Vol 17, Iss C, Pp 93-95 (2016)
Gynecologic Oncology Reports, Vol 17, Iss C, Pp 93-95 (2016)
Highlights • First reported case of PPC after BSO in a BRCA1/2-negative, PALB2-positive patient • The PALB2 mutation and genetic counseling is discussed • Multi-gene panel testing can benefit prognostic factors and targeted therapy
Publikováno v:
Immunologic Research. 57:311-325
Over the past decade, our laboratory has developed a secreted heat shock protein (HSP), chaperone gp96, cell-based vaccine that generates effective anti-tumor and anti-infectious immunity in vivo. Gp96-peptide complexes were identified as an extremel
Autor:
Wilberto Nieves-Neira, Natasa Strbo, Fiona Simpkins, Feng Miao, Eckhard R. Podack, Arlene E. Garcia-Soto, Tulay Koru-Sengul, Joseph A. Lucci, Parvin Ganjei-Azar, Taylor H. Schreiber
Publikováno v:
Gynecologic oncology. 145(3)
Objectives Cancer-testis (CT) antigens have been proposed as potential targets for cancer immunotherapy. Our objective was to evaluate the expression of a panel of CT antigens in epithelial ovarian cancer (EOC) tumor specimens, and to determine if an
Autor:
Angeles Alvarez Secord, Larry J. Copeland, James J. Java, J. Matthew Pearson, Wilberto Nieves Neira, Arlene E. Garcia-Soto, Joan L. Walker, Deborah K. Armstrong, David E. Cohn, Krishnansu S. Tewari, Shashikant Lele
Publikováno v:
Garcia-Soto, AE; Java, JJ; Nieves Neira, W; Pearson, JM; Cohn, DE; Lele, SB; et al.(2016). Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study. Gynecologic Oncology, 143(3), 484-489. doi: 10.1016/j.ygyno.2016.10.003. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/3373n99g
© 2016 Elsevier Inc. Objectives To determine the relationship of the time from surgery to intraperitoneal (IP) chemotherapy (TSIC) initiation with survival of patients with stage III epithelial ovarian cancer (EOC) patients using ancillary data from
Ovarian cancer (OVCA) is the most lethal gynecological malignancy. It is often diagnosed in advanced stages and despite therapy, 70% relapse within 2 years with incurable disease. Regimens with clinical benefit and minimal toxicity are urgently neede
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45355c573f702be01a7594eb63373bc7
https://europepmc.org/articles/PMC4551472/
https://europepmc.org/articles/PMC4551472/
Publikováno v:
ResearcherID
Objective Patients with ovarian cancer may have occult metastasis at the time of surgery. Our purpose was to determine the prevalence and sites of occult metastasis in epithelial ovarian cancer grossly confined to the ovary and examine the significan
Autor:
Rosa P. Castillo, J.M. Pearson, Joseph A. Lucci, Lilie L. Lin, Arlene E. Garcia-Soto, Fiona Simpkins, Jennifer J. Hu, Nathalie Dauphin McKenzie, Lorraine Portelance
Publikováno v:
Journal of Clinical Oncology. 33:TPS5619-TPS5619
TPS5619 Background: Despite platinum based chemoradiation (C-XRT), 40-50% of women with locally advanced cervical cancer will die from their disease. Nelfinavir (NFV), a protease inhibitor, has bee...